Brief: Moonlake Secures Up To $500 Million In Non-Dilutive Financing From Hercules Capital And Announces A Capital Markets Update On April 29 To Provide Important Clinical Updates
03/04/2025 12:27
April 3 (Reuters) - MoonLake Immunotherapeutics MLTX.O: MOONLAKE SECURES UP TO $500 MILLION IN NON-DILUTIVE FINANCING FROM HERCULES CAPITAL AND ANNOUNCES A CAPITAL MARKETS UPDATE ON APRIL 29 TO PROVIDE IMPORTANT CLINICAL UPDATES Source text: ID:nGNX5nzGGx Further company coverage: MLTX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on MoonLake Immunotherapeutics
See all newsMoonLake jumps as AbbVie's weak skin drug data eases competition fears
Brief: Moonlake Immunotherapeutics Files For Mixed Shelf Offering, Size Not Disclosed
MoonLake Immunotherapeutics reports results for the quarter ended June 30 - Earnings Summary
MoonLake's psoriatic arthritis drug meets key goals in late-stage trial (updated)
MoonLake's psoriatic arthritis drug meets key goals in late-stage trial